Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines episode artwork

EPISODE · Dec 11, 2024 · 1H 2M

Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines

from The Long Run with Luke Timmerman · host Timmerman Report

Alnylam Pharmaceuticals chief scientific officer Kevin Fitzgerald on the past, present & future of RNA interference medicines.

Alnylam Pharmaceuticals chief scientific officer Kevin Fitzgerald on the past, present & future of RNA interference medicines.

NOW PLAYING

Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines

0:00 1:02:28

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Long Run with Luke Timmerman?

This episode is 1 hour and 2 minutes long.

When was this The Long Run with Luke Timmerman episode published?

This episode was published on December 11, 2024.

What is this episode about?

Alnylam Pharmaceuticals chief scientific officer Kevin Fitzgerald on the past, present & future of RNA interference medicines.

Can I download this The Long Run with Luke Timmerman episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!